Dual Triple Anti-thrombotic Therapy Post-PCI

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

PART 1: Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillation - Scope of the Problem and Key Challenges

Published: 21 May 2020

Views:
281
Likes:
1

Average (ratings)

No ratings

Your rating

Prof Jan Steffel (Univerity He art Center, Zurich, CH), Prof Jur ten Berg (St Anthonius Hospital, Nieuwegein, NL) and Prof Stefan Hohnloser (JW Goethe University, Frankfurt, DE) discuss Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillaiton.

This discussion was funded by an unrestricted educational service from Boehringer Ingelheim